Mackenzie Anderson, MS CF-SLP | |
9 Summit Ave, Asheville, NC 28803-2880 | |
(828) 670-8056 | |
Not Available |
Full Name | Mackenzie Anderson |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 9 Summit Ave, Asheville, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073184073 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mackenzie Anderson, MS CF-SLP 2508 River Ridge Dr, Asheville, NC 28803-1075 Ph: (631) 972-4241 | Mackenzie Anderson, MS CF-SLP 9 Summit Ave, Asheville, NC 28803-2880 Ph: (828) 670-8056 |
News Archive
China Pediatric Pharmaceuticals, Inc., today announced its financial results for the third quarter ended September 30, 2010. The Company's quarterly report on Form 10-Q was filed with the U.S. Securities Exchange Commission on November 22, 2010.
Weekly sessions of non-invasive repetitive transcranial magnetic stimulation provided sufficient long-term pain relief in 61 percent of patients with central post-stroke pain, and delivered long-term relief for patients who continued for one year, according to a study presented at the International Neuromodulation Society 12th World Congress by Masahito Kobayashi, MD, PhD, of the Department of Neurosurgery, Saitama Medical University - Department of Neurology, Institute of Brain and Blood Vessels, Mihara Memorial Hospital in Saitama, Japan.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, announced today that it is terminating its previously announced proposed public offering pursuant to a preliminary prospectus supplement and an effective shelf registration statement on file with the Securities and Exchange Commission due to market conditions.
A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber Cancer Institute investigators at the San Antonio Breast Cancer Symposium.
› Verified 6 days ago
Ms. Erin Spainhour, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 85 W Walnut St, Apt. 406, Asheville, NC 28801 Phone: 336-592-5882 | |
Jennifer Yoelson Frome, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Brevard Rd, Asheville, NC 28806 Phone: 828-772-7101 | |
Mr. Samuel Clemons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Concord Pl, Asheville, NC 28803 Phone: 828-620-0729 | |
Melissa May Larsen, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Summit Ave, Ste. B, Asheville, NC 28803 Phone: 828-670-8056 Fax: 828-670-8057 | |
Sterling Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Kenilworth Rd, Asheville, NC 28803 Phone: 828-367-7044 | |
Melody Coffel, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Alclare Dr, Asheville, NC 28804 Phone: 407-222-2970 | |
Samantha Campbell, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 856 Sweeten Creek Rd Ste F, Asheville, NC 28803 Phone: 828-684-7337 |